CardiaCare is a groundbreaking brand that offers non-invasive personalized neuromodulation therapy for Atrial Fibrillation (AF), a condition that affects millions of people worldwide. Unlike other wearables, CardiaCare goes beyond tracking and delivers therapy directly to the wrist, providing a new approach in AF care. Using a digital neuromodulation wearable with closed loop monitoring and machine learning algorithms, CardiaCare aims to reduce AF burden, symptoms, and recurrence.

The device utilizes remote cardiac monitoring, health cloud software analysis, and neuromodulation therapy to reduce arrhythmia. By acquiring personal data through optical and electrical sensors, the device generates personalized therapy through machine learning algorithms. CardiaCare's therapy works by neuromodulating the nerves in the wrist, which then reaches the brain, balancing sympathetic and Vagal nerve control over heart rate and rhythm.

This results in immediate relief of arrhythmia symptoms and a reduction in AF recurrence rates. With its Health Cloud, CardiaCare utilizes a large patient-specific database to generate optimized care through machine learning algorithms and scientific research. Users of CardiaCare have reported less and shorter episodes of AF, reduced symptoms, and an improved quality of life.

CardiaCare is revolutionizing the way AF is managed and providing a simple, effective home-care system for individuals with AF